|
The clinical and economic impact of a generic first-line antiretroviral regimen in the U.S.
|
FRLBX06
|
Time:
12:05
Speaker:
Rochelle P. Walensky
You can download the video file
here
For more information on this presentation, including access to speaker presentations,
please see the conference
Programme-at-a-Glance page.